Expansion and shrinkage of central nervous system tumor coinciding with human growth hormone therapy: Case report

被引:9
作者
Connors, MH
Boggan, JE
Chong, B
Kollipara, S
机构
[1] UNIV CALIF DAVIS,MED CTR,DEPT NEUROSURG,SACRAMENTO,CA 95817
[2] UNIV CALIF DAVIS,MED CTR,DEPT RADIOL,SACRAMENTO,CA 95817
关键词
astrocytoma; growth; growth hormone; magnetic resonance imaging; tumor growth;
D O I
10.1097/00006123-199612000-00037
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE AND IMPORTANCE: The influence of human growth hormone (hGH) therapy on the recurrence rates of childhood central nervous system tumors is controversial. Because growth hormone has the ability to increase cell proliferation, it is recommended that hGH therapy wait until central nervous system lesions are inactive and antitumor therapy complete, usually 1 to 2 years. CLINICAL PRESENTATION: We report the enlargement and decrease in size of a hypothalamic pilocytic astrocytoma in a 12-year-old boy after two trials of hGH. Partial resection and radiation of the tumor were performed at 3 years of age, with no change noted over the next 9 years. His height was less than the 5th centile with midparental height at the 90th to 95th centiles. Growth velocity was 3.3 cm/yr. Bone age was normal and there were no signs of puberty. There was no GH response to clonidine and L-dopa testing. INTERVENTION: Volume measurements were performed on gadolinium enhanced tumor images. Growth rate increased to 11.7 cm and the tumor volume increased 230% over the 12 months of hGH therapy. Significant tumor shrinkage (42%) and growth deceleration occurred within the 3 month interval of stopping hGH. Tumor volume again increased (134%) and decreased (22%) after restarting and then stopping hGH. No evidence of tumor necrosis or alteration in ventricular size was found. The patient was asymptomatic. CONCLUSION: These observations indicate that tumor size change is associated with the metabolic response to hGH therapy. It is unclear whether the volume increase represents altered blood-brain or selective blood-tumor barrier permeability, growth factor receptors, and/or tumor cell growth.
引用
收藏
页码:1243 / 1245
页数:3
相关论文
共 10 条
[1]   GROWTH-HORMONE THERAPY AND TUMOR RECURRENCE - FINDINGS IN CHILDREN WITH BRAIN NEOPLASMS AND HYPOPITUITARISM [J].
ARSLANIAN, SA ;
BECKER, DJ ;
LEE, PA ;
DRASH, AL ;
FOLEY, TP .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1985, 139 (04) :347-350
[2]  
CLAYTON PE, 1987, LANCET, V1, P711
[3]   PILOCYTIC ASTROCYTOMAS - WELL-DEMARCATED MAGNETIC-RESONANCE APPEARANCE DESPITE FREQUENT INFILTRATION HISTOLOGICALLY [J].
COAKLEY, KJ ;
HUSTON, J ;
SCHEITHAUER, BW ;
FORBES, G ;
KELLY, PJ .
MAYO CLINIC PROCEEDINGS, 1995, 70 (08) :747-751
[4]  
GAMMELTOFT S, 1988, CANCER RES, V48, P1233
[5]  
Greulich W.W., 1971, RADIOGRAPHIC ATLAS S
[6]   AN ASSESSMENT OF GROWTH-HORMONE PROVOCATION TESTS [J].
HINDMARSH, PC ;
SWIFT, PGF .
ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 72 (04) :362-367
[7]   BENIGN INTRACRANIAL HYPERTENSION IN CHILDREN WITH GROWTH-HORMONE DEFICIENCY TREATED WITH GROWTH-HORMONE [J].
MALOZOWSKI, S ;
TANNER, LA ;
WYSOWSKI, DK ;
FLEMING, GA ;
STADEL, BV .
JOURNAL OF PEDIATRICS, 1995, 126 (06) :996-999
[8]  
MIXSON AJ, 1993, J CLIN ENDOCR METAB, V76, P529, DOI 10.1210/jcem.76.2.8432799
[9]   CHRONIC NEUROENDOCRINOLOGICAL SEQUELAE OF RADIATION-THERAPY [J].
SKLAR, CA ;
CONSTINE, LS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05) :1113-1121
[10]  
WATANABE H, 1991, NERUOL SURG, V20, P1009